Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation

European Respiratory Journal

Volumn 23, Issue 3, 2004, Pages 440-445

  Nusair, Samjack ^a   Breuer, R ^a   Shapira, M Y ^a   Berkman, N ^a   Or, R ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bronchiolitis obliterans; Diffuse alveolar haemorrhage; Idiopathic pneumonia syndrome; Nonmyeloablative; Stem cell transplantation

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; ATG FRESENIUS AG; BUSULFAN; CEFAZOLIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; ERYTHROMYCIN; FLUDARABINE; G NEUPOGEN; GANCICLOVIR; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; MEZLOCILLIN; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; BACTERIAL PNEUMONIA; BRONCHIOLITIS; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFORMATION PROCESSING; INFORMATION RETRIEVAL; LUNG BIOPSY; LUNG COMPLICATION; LUNG EDEMA; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG MYCOSIS; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MICROBIAL CONTAMINATION; MUCORMYCOSIS; OUTCOMES RESEARCH; PATIENT INFORMATION; PLEURA EFFUSION; PNEUMOCYSTOSIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; MALE; PNEUMONIA; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION CONDITIONING;

EID: 1542714266     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00053004     Document Type: Review

References (29)

1. Wingard JR, Mellits ED, Sostrin MB, et al. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine (Baltimore) 1988; 67: 175-186.
2. Weiner RS, Bortin MM, Gale RP, et al. Interstitial pneumonitis after bone marrow transplantation: Assessment of risk factors. Ann Intern Med 1986; 104: 168-175.
3. Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW. Idiopathic pneumonia syndrome: Changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63: 1079-1086.
4. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-763.
5. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
6. Breuer R, Or R, Lijovetzky G, et al. Interstitial pneumonitis in T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1988; 3: 625-630.
7. Greenwood M. The natural duration of cancer. Rep Public Health Med Subj (Lond) 1926; 33: 1-26.
8. Glazer M, Nusair S, Breuer R, Lafair J, Sherman Y, Berkman N. The role of bronchoalveolar lavage in the diagnosis of pulmonary mucormycosis. Chest 2000; 117: 279-282.
9. Cordonnier C, Bernaudin JF, Bierling P, Huet Y, Vernant JP. Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer 1986; 58: 1047-1054.
10. Wingard JR, Sostrin MB, Vriesendorp HM, et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1988; 46: 61-65.
11. Pecego R, Hill R, Appelbaum FR, et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1986; 42: 515-517.
12. Apperley JF, Jones L, Hale G, et al. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant 1986; 1: 53-66.
13. Butturini A, Gale RP. T cell depletion in bone marrow transplantation for leukemia: Current results and future directions. Bone Marrow Transplant 1988; 3: 185-192.
14. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068-1073.
15. Bornhauser M, Thiede C, Platzbecker U, et al. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clin Cancer Res 2001; 7: 2254-2262.
16. Kelemen E, Masszi T, Remenyi P, Barta A, Paloczi K. Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination. Bone Marrow Transplant 1998; 21: 747-749.
17. Mohty M, Faucher C, Vey N, et al. High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation. Bone Marrow Transplant 2000; 26: 251-255.
18. Nachbaur D, Larcher C, Kircher B, et al. Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation. Ann Hematol 2003; 82: 621-627.
19. Daly A, McAfee S, Dey B, et al. Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants. Biol Blood Marrow Transplant 2003; 9: 373-382.
20. Hagen EA, Stern H, Porter D, et al. High rate of invasive fungal infections following nonmyeloablative, allogeneic transplantation. Clin Infect Dis 2003; 36: 9-15.
21. Robbins RA, Linder J, Stahl MG, et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 1989; 87: 511-518.
22. Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223-229.
23. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1601-1606.
24. Weshler Z, Breuer R, Or R, et al. Interstitial pneumonitis after total body irradiation: Effect of partial lung shielding. Br J Haematol 1990; 74: 61-64.
25. Shankar G, Bryson JS, Jennings CD, Kaplan AM, Cohen DA. Idiopathic pneumonia syndrome after allogeneic bone marrow transplantation in mice: Role of pretransplant radiation conditioning. Am J Respir Cell Mol Biol 1999; 20: 1116-1124.
26. Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107: 648-656.
27. Chan CK, Hyland RH, Hutcheon MA, Minden MD, Alexander MA, Kossakowka AE. Small airways disease in recipients of allogeneic bone marrow transplants: An analysis of 11 cases and a review of the literature. Medicine 1987; 66: 327-340.
28. Palmas A, Tefferi A, Myers JL, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998; 100: 680-687.
29. Paz HL, Crilley P, Patchefsky A, Schiffman RL, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101: 775-778.